LYKALABS.BO

Lyka Labs Limited is an Indian pharmaceutical firm engaged in the development, production, and commercialization of both pharmaceutical formulations and active pharmaceutical ingredients (APIs). Its operations span diverse therapeutic areas primarily within India, though it also has an international presence. Its extensive product portfolio encompasses a broad spectrum of pharmaceutical formulations. These include a variety of dermatologicals (such as emollients, topical steroids, antifungals, and acne treatments), pain management solutions, anti-aging products, hair care items, and sunscreens. Beyond these, Lyka Labs offers specialized formulations like proton pump inhibitors, anti-malarials, antibiotics (including cephalosporins and dry powder injectables), corticosteroid hormones, bone resorption inhibitors, and lyophilized products. These products are available in diverse delivery formats, such as injectable solutions, creams, ointments, foams, gels, and lotions. In addition to its proprietary offerings, Lyka Labs provides contract manufacturing services for other major pharmaceutical entities. It further extends its expertise through medical and technical support, covering manufacturing know-how, facility guidance, and crucial technical documentation like molecule stability data, impurity profiling, and bioequivalence (BA/BE) clinical study results. The company also caters to a range of therapeutic segments, including intensive care, gastroenterology, anti-infectives, anti-fungals, surgical care, cosmetology, urology, wound management, and anesthesiology. Established in 1976 and headquartered in Mumbai, India, Lyka Labs also distributes its products internationally.